IHM
PTCT icon

Iguana Healthcare Management’s PTC Therapeutics PTCT Stock Holding History

Iguana Healthcare Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-25,000
Closed -$1.52M – 85
2015
Q1 		$1.52M Buy
+25,000
New +$1.53M 0.64% 46

Other funds holding PTCT

SCM
Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
SIM
Spark Investment Management New York $51.2M AUM 87.14% 1-Year Est. Return

Iguana Healthcare Management's PTCT Position: Q2 2015 in Review

Iguana Healthcare Management sold out of PTC Therapeutics (PTCT) in Q2 2015, closing a stake of 25,000 shares — an estimated $1.52M sold.

Iguana Healthcare Management first reported a position in PTCT in Q1 2015 and held it in 1 quarter. The position peaked at $1.52M in Q1 2015. 155 funds tracked by Wall St. Rank hold PTCT as of Q2 2015.

  • Iguana Healthcare Management reported no remaining PTC Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Iguana Healthcare Management sold 25,000 PTC Therapeutics shares in Q2 2015, an estimated $1.52M.
  • Iguana Healthcare Management first reported a position in PTC Therapeutics in Q1 2015 and held it in 1 quarter.
  • Iguana Healthcare Management's PTC Therapeutics position peaked at $1.52M in Q1 2015.
  • 155 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2015.

Based on Iguana Healthcare Management's 13F filing for Q2 2015, filed 14 Aug 2015.